Patrick Trucchio
Stock Analyst at H.C. Wainwright
(4.96)
# 139
Out of 4,460 analysts
1173
Total ratings
58.4%
Success rate
35.3%
Average return
Main Sectors:
Stocks Rated by Patrick Trucchio
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ARWR Arrowhead Pharmaceuticals | Reiterated: Buy | $100 | $81.46 | +22.76% | 68 | Jul 1, 2026 | |
| ALNY Alnylam Pharmaceuticals | Reiterated: Buy | $510 → $470 | $305.36 | +53.92% | 73 | Jun 29, 2026 | |
| QURE uniQure | Reiterated: Buy | $50 → $80 | $45.91 | +74.25% | 61 | Jun 29, 2026 | |
| VYGR Voyager Therapeutics | Reiterated: Buy | $25 | $3.50 | +615.31% | 25 | Jun 25, 2026 | |
| NRXP NRx Pharmaceuticals | Reiterated: Buy | $45 | $3.94 | +1,042.13% | 11 | Jun 25, 2026 | |
| GOSS Gossamer Bio | Reiterated: Buy | $5 → $2 | $0.1677 | +1,092.61% | 49 | Jun 25, 2026 | |
| CMPS COMPASS Pathways | Reiterated: Buy | $70 | $13.81 | +406.88% | 58 | Jun 25, 2026 | |
| DRUG Bright Minds Biosciences | Reiterated: Buy | $145 | $68.40 | +111.99% | 14 | Jun 25, 2026 | |
| ATAI AtaiBeckley | Reiterated: Buy | $25 | $4.85 | +415.46% | 54 | Jun 25, 2026 | |
| ANRO Alto Neuroscience | Reiterated: Buy | $50 | $25.42 | +96.70% | 20 | Jun 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $70 | $44.25 | +58.19% | 44 | Jun 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $55 | $36.04 | +52.61% | 24 | Jun 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $60 | $23.42 | +156.19% | 1 | Jun 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $35 | $12.24 | +186.06% | 1 | Jun 22, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | 1,000p | $41.00 | +2,339.02% | 25 | Jun 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $75 | $10.56 | +610.23% | 42 | Jun 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $60 | $33.70 | +78.04% | 9 | Jun 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 | $0.8512 | +1,074.81% | 37 | Jun 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.051 | - | 51 | Jun 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $20 | $3.28 | +509.76% | 48 | Jun 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $50 | $26.88 | +86.01% | 14 | Jun 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $60 | $7.92 | +657.58% | 64 | Jun 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $20 | $9.65 | +107.25% | 66 | Jun 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $50 | $5.53 | +804.16% | 19 | Jun 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $100 | $31.66 | +215.86% | 52 | Jun 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 | $0.9121 | +996.37% | 49 | May 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $80 | $34.38 | +132.69% | 26 | May 21, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 | $1.48 | +575.68% | 6 | May 19, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $70 → $65 | $26.84 | +142.18% | 39 | May 19, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $95 | $6.51 | +1,359.29% | 42 | Apr 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $25 → $10 | $1.34 | n/a | 34 | Apr 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $20 → $360 | $12.57 | n/a | 14 | May 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $12.93 | n/a | 5 | Feb 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.05 | n/a | 5 | Feb 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | 100p → 46p | $6.30 | n/a | 3 | Nov 2, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | €33.00 | $5.10 | n/a | 10 | Mar 27, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $66 → $24 | $46.28 | n/a | 2 | Nov 8, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $120 → $130 | $14.95 | n/a | 3 | Sep 18, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $117 → $72 | $10.45 | n/a | 2 | Nov 13, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $25 | $4.16 | n/a | 1 | Apr 19, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $22 | $22.33 | n/a | 1 | Apr 19, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $125 | $111.02 | n/a | 1 | Dec 23, 2014 |
Arrowhead Pharmaceuticals
Jul 1, 2026
Reiterated: Buy
Price Target: $100
Current: $81.46
Upside: +22.76%
Alnylam Pharmaceuticals
Jun 29, 2026
Reiterated: Buy
Price Target: $510 → $470
Current: $305.36
Upside: +53.92%
uniQure
Jun 29, 2026
Reiterated: Buy
Price Target: $50 → $80
Current: $45.91
Upside: +74.25%
Voyager Therapeutics
Jun 25, 2026
Reiterated: Buy
Price Target: $25
Current: $3.50
Upside: +615.31%
NRx Pharmaceuticals
Jun 25, 2026
Reiterated: Buy
Price Target: $45
Current: $3.94
Upside: +1,042.13%
Gossamer Bio
Jun 25, 2026
Reiterated: Buy
Price Target: $5 → $2
Current: $0.1677
Upside: +1,092.61%
COMPASS Pathways
Jun 25, 2026
Reiterated: Buy
Price Target: $70
Current: $13.81
Upside: +406.88%
Bright Minds Biosciences
Jun 25, 2026
Reiterated: Buy
Price Target: $145
Current: $68.40
Upside: +111.99%
AtaiBeckley
Jun 25, 2026
Reiterated: Buy
Price Target: $25
Current: $4.85
Upside: +415.46%
Alto Neuroscience
Jun 25, 2026
Reiterated: Buy
Price Target: $50
Current: $25.42
Upside: +96.70%
Jun 23, 2026
Reiterated: Buy
Price Target: $70
Current: $44.25
Upside: +58.19%
Jun 23, 2026
Reiterated: Buy
Price Target: $55
Current: $36.04
Upside: +52.61%
Jun 23, 2026
Initiated Coverage: Buy
Price Target: $60
Current: $23.42
Upside: +156.19%
Jun 22, 2026
Initiated Coverage: Buy
Price Target: $35
Current: $12.24
Upside: +186.06%
Jun 17, 2026
Reiterated: Buy
Price Target: 1,000p
Current: $41.00
Upside: +2,339.02%
Jun 17, 2026
Reiterated: Buy
Price Target: $75
Current: $10.56
Upside: +610.23%
Jun 16, 2026
Reiterated: Buy
Price Target: $60
Current: $33.70
Upside: +78.04%
Jun 16, 2026
Reiterated: Buy
Price Target: $10
Current: $0.8512
Upside: +1,074.81%
Jun 9, 2026
Rated: Hold
Price Target: n/a
Current: $0.051
Upside: -
Jun 3, 2026
Maintained: Buy
Price Target: $20
Current: $3.28
Upside: +509.76%
Jun 3, 2026
Reiterated: Buy
Price Target: $50
Current: $26.88
Upside: +86.01%
Jun 3, 2026
Reiterated: Buy
Price Target: $60
Current: $7.92
Upside: +657.58%
Jun 3, 2026
Reiterated: Buy
Price Target: $20
Current: $9.65
Upside: +107.25%
Jun 3, 2026
Reiterated: Buy
Price Target: $50
Current: $5.53
Upside: +804.16%
Jun 3, 2026
Reiterated: Buy
Price Target: $100
Current: $31.66
Upside: +215.86%
May 29, 2026
Reiterated: Buy
Price Target: $10
Current: $0.9121
Upside: +996.37%
May 21, 2026
Reiterated: Buy
Price Target: $80
Current: $34.38
Upside: +132.69%
May 19, 2026
Reiterated: Buy
Price Target: $10
Current: $1.48
Upside: +575.68%
May 19, 2026
Reiterated: Buy
Price Target: $70 → $65
Current: $26.84
Upside: +142.18%
Apr 28, 2026
Reiterated: Buy
Price Target: $95
Current: $6.51
Upside: +1,359.29%
Apr 2, 2025
Maintained: Buy
Price Target: $25 → $10
Current: $1.34
Upside: n/a
May 15, 2023
Maintained: Buy
Price Target: $20 → $360
Current: $12.57
Upside: n/a
Feb 10, 2023
Rated: Hold
Price Target: n/a
Current: $12.93
Upside: n/a
Feb 10, 2023
Rated: Hold
Price Target: n/a
Current: $0.05
Upside: n/a
Nov 2, 2022
Reiterated: Buy
Price Target: 100p → 46p
Current: $6.30
Upside: n/a
Mar 27, 2020
Maintained: Buy
Price Target: €33.00
Current: $5.10
Upside: n/a
Nov 8, 2019
Downgraded: Hold
Price Target: $66 → $24
Current: $46.28
Upside: n/a
Sep 18, 2019
Maintained: Buy
Price Target: $120 → $130
Current: $14.95
Upside: n/a
Nov 13, 2018
Downgraded: Hold
Price Target: $117 → $72
Current: $10.45
Upside: n/a
Apr 19, 2018
Initiated Coverage: Buy
Price Target: $25
Current: $4.16
Upside: n/a
Apr 19, 2018
Initiated Coverage: Buy
Price Target: $22
Current: $22.33
Upside: n/a
Dec 23, 2014
Upgraded: Buy
Price Target: $125
Current: $111.02
Upside: n/a